Published in Proc Natl Acad Sci U S A on January 02, 2008
PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res (2008) 6.73
Specific DNA-binding by apicomplexan AP2 transcription factors. Proc Natl Acad Sci U S A (2008) 3.10
The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites. Cell Host Microbe (2008) 2.98
New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. Mol Microbiol (2010) 2.76
Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol (2008) 2.49
Identification and genome-wide prediction of DNA binding specificities for the ApiAP2 family of regulators from the malaria parasite. PLoS Pathog (2010) 2.00
Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog (2008) 1.98
Malarial proteases and host cell egress: an 'emerging' cascade. Cell Microbiol (2008) 1.86
Malaria research in the post-genomic era. Nature (2008) 1.78
A pre-emptive strike against malaria's stealthy hepatic forms. Nat Rev Drug Discov (2009) 1.77
The Apicomplexan AP2 family: integral factors regulating Plasmodium development. Mol Biochem Parasitol (2010) 1.74
A multifunctional serine protease primes the malaria parasite for red blood cell invasion. EMBO J (2009) 1.67
Host cell phosphatidylcholine is a key mediator of malaria parasite survival during liver stage infection. Cell Host Microbe (2014) 1.66
A sporozoite asparagine-rich protein controls initiation of Plasmodium liver stage development. PLoS Pathog (2008) 1.65
Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe (2011) 1.61
Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc Natl Acad Sci U S A (2013) 1.57
Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics (2011) 1.53
Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest (2012) 1.52
Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events. BMC Genomics (2009) 1.52
Malaria parasite development in the mosquito and infection of the mammalian host. Annu Rev Microbiol (2009) 1.52
Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum Vaccin (2010) 1.50
Quantitative protein expression profiling reveals extensive post-transcriptional regulation and post-translational modifications in schizont-stage malaria parasites. Genome Biol (2008) 1.48
UIS2: A Unique Phosphatase Required for the Development of Plasmodium Liver Stages. PLoS Pathog (2016) 1.40
Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl Trop Dis (2010) 1.39
Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein. PLoS One (2016) 1.39
A comprehensive evaluation of rodent malaria parasite genomes and gene expression. BMC Biol (2014) 1.31
Malaria parasite pre-erythrocytic stage infection: gliding and hiding. Cell Host Microbe (2008) 1.30
Histone deacetylases play a major role in the transcriptional regulation of the Plasmodium falciparum life cycle. PLoS Pathog (2010) 1.27
Systems pharmacology and genome medicine: a future perspective. Genome Med (2009) 1.26
Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PLoS One (2008) 1.25
HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites. J Infect Dis (2009) 1.24
Apicoplast and mitochondrion in gametocytogenesis of Plasmodium falciparum. Eukaryot Cell (2008) 1.20
Looking under the skin: the first steps in malarial infection and immunity. Nat Rev Microbiol (2013) 1.20
Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis. BMC Syst Biol (2010) 1.19
Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection. PLoS Pathog (2008) 1.19
Quantitative time-course profiling of parasite and host cell proteins in the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics (2011) 1.17
Identification of an AP2-family protein that is critical for malaria liver stage development. PLoS One (2012) 1.17
Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host. Mol Cell Biol (2008) 1.17
Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites. J Infect Dis (2014) 1.16
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. Antimicrob Agents Chemother (2014) 1.14
Role of Plasmodium berghei cGMP-dependent protein kinase in late liver stage development. J Biol Chem (2009) 1.13
Meta-analysis of heat- and chemically upregulated chaperone genes in plant and human cells. Cell Stress Chaperones (2010) 1.10
Plasmodium sporozoite-host interactions from the dermis to the hepatocyte. Curr Opin Microbiol (2009) 1.10
Plasmodium immunomics. Int J Parasitol (2010) 1.09
Suppression of host p53 is critical for Plasmodium liver-stage infection. Cell Rep (2013) 1.08
Pre-erythrocytic malaria vaccines: identifying the targets. Expert Rev Vaccines (2012) 1.07
Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect Immun (2010) 1.06
Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci Rep (2013) 1.06
LISP1 is important for the egress of Plasmodium berghei parasites from liver cells. Cell Microbiol (2009) 1.06
Transition of Plasmodium sporozoites into liver stage-like forms is regulated by the RNA binding protein Pumilio. PLoS Pathog (2011) 1.06
Metamorphosis of the malaria parasite in the liver is associated with organelle clearance. Cell Res (2010) 1.06
Malaria parasite pre-erythrocytic infection: preparation meets opportunity. Cell Microbiol (2012) 1.06
Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds. Mol Biochem Parasitol (2010) 1.06
Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways. PLoS One (2011) 1.04
Recent advances in malaria drug discovery. Bioorg Med Chem Lett (2013) 1.04
The next opportunity in anti-malaria drug discovery: the liver stage. PLoS Pathog (2011) 1.04
The origins of apicomplexan sequence innovation. Genome Res (2009) 1.03
Central carbon metabolism of Plasmodium parasites. Mol Biochem Parasitol (2010) 1.02
Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites. Mol Biochem Parasitol (2012) 1.00
Cloning of Plasmodium falciparum by single-cell sorting. Exp Parasitol (2010) 0.99
Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes. Eukaryot Cell (2013) 0.98
Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat Rev Microbiol (2013) 0.98
Inactivation of a Plasmodium apicoplast protein attenuates formation of liver merozoites. Mol Microbiol (2011) 0.97
Rapid isolation of single malaria parasite-infected red blood cells by cell sorting. Nat Protoc (2011) 0.96
Epigenetics in Plasmodium: what do we really know? Eukaryot Cell (2010) 0.96
Long-term live imaging reveals cytosolic immune responses of host hepatocytes against Plasmodium infection and parasite escape mechanisms. Autophagy (2015) 0.96
The exported Plasmodium berghei protein IBIS1 delineates membranous structures in infected red blood cells. Mol Microbiol (2012) 0.95
Transcriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoelii. PLoS One (2010) 0.95
High mobility group protein HMGB2 is a critical regulator of plasmodium oocyst development. J Biol Chem (2008) 0.94
Predicting and exploring network components involved in pathogenesis in the malaria parasite via novel subnetwork alignments. BMC Syst Biol (2015) 0.94
Plasmodium protease ROM1 is important for proper formation of the parasitophorous vacuole. PLoS Pathog (2011) 0.93
Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya. J Infect Dis (2015) 0.93
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections. Bioorg Med Chem (2010) 0.93
Mitochondrial ATP synthase is dispensable in blood-stage Plasmodium berghei rodent malaria but essential in the mosquito phase. Proc Natl Acad Sci U S A (2015) 0.93
Identification and characterization of a liver stage-specific promoter region of the malaria parasite Plasmodium. PLoS One (2010) 0.93
The malarial serine protease SUB1 plays an essential role in parasite liver stage development. PLoS Pathog (2013) 0.91
Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of Malaria hypnozoite-forms. PLoS One (2013) 0.91
A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations. Proc Natl Acad Sci U S A (2013) 0.91
Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle. Antimicrob Agents Chemother (2011) 0.91
A systematic analysis of the early transcribed membrane protein family throughout the life cycle of Plasmodium yoelii. Cell Microbiol (2011) 0.91
Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profiling. PLoS Pathog (2013) 0.91
New Agilent platform DNA microarrays for transcriptome analysis of Plasmodium falciparum and Plasmodium berghei for the malaria research community. Malar J (2012) 0.90
Assessment and improvement of the Plasmodium yoelii yoelii genome annotation through comparative analysis. Bioinformatics (2008) 0.90
Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine (2008) 0.90
Recent Progress in Functional Genomic Research in Plasmodium falciparum. Curr Genomics (2010) 0.90
CD8 T-cell-mediated protection against liver-stage malaria: lessons from a mouse model. Front Microbiol (2014) 0.89
Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities. Infect Immun (2014) 0.89
CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection. Infect Immun (2013) 0.89
Characterization of Plasmodium liver stage inhibition by halofuginone. ChemMedChem (2012) 0.88
A dispensable Plasmodium locus for stable transgene expression. Mol Biochem Parasitol (2010) 0.87
A key role for lipoic acid synthesis during Plasmodium liver stage development. Cell Microbiol (2013) 0.87
Proteomic analysis of Plasmodium in the mosquito: progress and pitfalls. Parasitology (2012) 0.87
Novel approaches to identify protective malaria vaccine candidates. Front Microbiol (2014) 0.87
Advances and challenges in malaria vaccine development. Expert Rev Mol Med (2009) 0.86
Invasion of mosquito salivary glands by malaria parasites: prerequisites and defense strategies. Int J Parasitol (2010) 0.85
Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa. Malar J (2011) 0.85
Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents. J Med Chem (2009) 0.84
Characterization of the ATG8-conjugation system in 2 Plasmodium species with special focus on the liver stage: possible linkage between the apicoplastic and autophagic systems? Autophagy (2013) 0.84
Module-based subnetwork alignments reveal novel transcriptional regulators in malaria parasite Plasmodium falciparum. BMC Syst Biol (2012) 0.84
Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses. Am J Trop Med Hyg (2012) 0.84
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73
The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol (2003) 11.86
A proteomic view of the Plasmodium falciparum life cycle. Nature (2002) 10.65
Discovery of gene function by expression profiling of the malaria parasite life cycle. Science (2003) 10.57
The pathogenic basis of malaria. Nature (2002) 10.44
Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature (2002) 8.92
Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature (1967) 6.08
A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science (2005) 5.99
Primaquine therapy for malaria. Clin Infect Dis (2004) 4.66
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature (2004) 4.35
Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat Rev Microbiol (2004) 3.85
Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat Med (2001) 3.34
Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A (2005) 3.06
Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol (2004) 2.92
The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol (2007) 2.47
Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci U S A (2003) 2.38
Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol (2003) 2.32
Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc Natl Acad Sci U S A (2002) 2.24
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature (1987) 2.02
Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis (2007) 1.99
Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother (2006) 1.95
Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol (2006) 1.83
Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun (2007) 1.79
A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J Exp Med (2005) 1.71
A role for falcilysin in transit peptide degradation in the Plasmodium falciparum apicoplast. Mol Microbiol (2006) 1.71
New antimalarial drugs. Angew Chem Int Ed Engl (2003) 1.68
Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc Natl Acad Sci U S A (1995) 1.55
Progress in in silico functional genomics: the malaria Metabolic Pathways database. Trends Parasitol (2006) 1.54
Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am J Pathol (2007) 1.51
Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J Biol Chem (1996) 1.25
Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression. Mol Biochem Parasitol (2005) 1.22
Malaria vaccines-targeting infected hepatocytes. Nat Med (2000) 1.21
Transcriptome of axenic liver stages of Plasmodium yoelii. Mol Biochem Parasitol (2004) 1.14
Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis. Biochem J (2006) 1.11
Malaria vaccines. Evaluation and implementation. Acta Trop (2005) 1.08
Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. Bioorg Med Chem Lett (2006) 1.05
Live and let die: manipulation of host hepatocytes by exoerythrocytic Plasmodium parasites. Med Microbiol Immunol (2007) 1.05
Functional proteome and expression analysis of sporozoites and hepatic stages of malaria development. Curr Top Microbiol Immunol (2005) 0.87
Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature (2002) 8.92
Malaria: progress, perils, and prospects for eradication. J Clin Invest (2008) 6.54
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature (2004) 4.35
Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A (2005) 3.06
Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol (2008) 2.49
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44
Transport and release of chemicals from plastics to the environment and to wildlife. Philos Trans R Soc Lond B Biol Sci (2009) 2.27
Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis (2007) 1.99
A comprehensive analysis of Trypanosoma brucei mitochondrial proteome. Proteomics (2009) 1.94
Myosin A tail domain interacting protein (MTIP) localizes to the inner membrane complex of Plasmodium sporozoites. J Cell Sci (2003) 1.85
Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage. J Biol Chem (2002) 1.83
Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol (2006) 1.83
Mitochondrial complexes in Trypanosoma brucei: a novel complex and a unique oxidoreductase complex. Mol Cell Proteomics (2007) 1.81
Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun (2007) 1.79
Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J Infect Dis (2007) 1.79
Compression of next-generation sequencing reads aided by highly efficient de novo assembly. Nucleic Acids Res (2012) 1.76
Differential transcriptome profiling identifies Plasmodium genes encoding pre-erythrocytic stage-specific proteins. Mol Microbiol (2004) 1.76
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A (2009) 1.72
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation. J Infect Dis (2013) 1.71
Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog (2007) 1.67
Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host Microbe (2008) 1.62
Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe (2011) 1.61
Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection. Mol Microbiol (2008) 1.56
Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials. Am J Trop Med Hyg (2012) 1.55
MicroRNA expression and virulence in pandemic influenza virus-infected mice. J Virol (2010) 1.54
Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest (2012) 1.52
Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events. BMC Genomics (2009) 1.52
Malaria parasite development in the mosquito and infection of the mammalian host. Annu Rev Microbiol (2009) 1.52
Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum Vaccin (2010) 1.50
L-FABP is a critical host factor for successful malaria liver stage development. Int J Parasitol (2007) 1.48
Apicomplexan gliding motility and host cell invasion: overhauling the motor model. Trends Parasitol (2004) 1.47
Trypanosoma brucei mitochondrial ribosomes: affinity purification and component identification by mass spectrometry. Mol Cell Proteomics (2008) 1.44
Evaluation of a no-pretreatment cyclosporin A assay on the Dade Behring dimension RxL clinical chemistry analyzer. Clin Chem (2002) 1.42
Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J Virol (2010) 1.40
A member of a conserved Plasmodium protein family with membrane-attack complex/perforin (MACPF)-like domains localizes to the micronemes of sporozoites. Mol Biochem Parasitol (2004) 1.38
Neuroimmunological blood brain barrier opening in experimental cerebral malaria. PLoS Pathog (2012) 1.35
Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System. Pharmacogenomics (2007) 1.30
Malaria parasite pre-erythrocytic stage infection: gliding and hiding. Cell Host Microbe (2008) 1.30
A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. J Biol Chem (2003) 1.26
Transformation of sporozoites into early exoerythrocytic malaria parasites does not require host cells. J Exp Med (2003) 1.26
Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection. Mol Microbiol (2010) 1.21
The distinct proteome of placental malaria parasites. Mol Biochem Parasitol (2007) 1.19
Total and putative surface proteomics of malaria parasite salivary gland sporozoites. Mol Cell Proteomics (2013) 1.19
Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol (2012) 1.18
Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host. Mol Cell Biol (2008) 1.17
Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials. Cell Host Microbe (2012) 1.16
First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Vaccine (2013) 1.16
The closed MTIP-myosin A-tail complex from the malaria parasite invasion machinery. J Mol Biol (2007) 1.15
The non-human primate reference transcriptome resource (NHPRTR) for comparative functional genomics. Nucleic Acids Res (2012) 1.13
Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii. PLoS One (2013) 1.11
Structure of the MTIP-MyoA complex, a key component of the malaria parasite invasion motor. Proc Natl Acad Sci U S A (2006) 1.09
Suppression of host p53 is critical for Plasmodium liver-stage infection. Cell Rep (2013) 1.08
The alpha/beta interferon receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling. J Virol (2009) 1.07
Malaria vaccine development: persistent challenges. Curr Opin Immunol (2012) 1.07
Genetic engineering of attenuated malaria parasites for vaccination. Curr Opin Biotechnol (2012) 1.06
Plasmodium falciparum MAEBL is a unique member of the ebl family. Mol Biochem Parasitol (2002) 1.06
Malaria parasite pre-erythrocytic infection: preparation meets opportunity. Cell Microbiol (2012) 1.06
SAP1 is a critical post-transcriptional regulator of infectivity in malaria parasite sporozoite stages. Mol Microbiol (2010) 1.04
Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites. PLoS One (2009) 1.04
Preerythrocytic malaria vaccine development. Curr Opin Infect Dis (2007) 1.03
Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites. Mol Biochem Parasitol (2012) 1.00
An efficient strategy for gene targeting and phenotypic assessment in the Plasmodium yoelii rodent malaria model. Mol Biochem Parasitol (2007) 1.00
P58(IPK): a novel "CIHD" member of the host innate defense response against pathogenic virus infection. PLoS Pathog (2009) 0.99
Structure-based design of novel small-molecule inhibitors of Plasmodium falciparum. J Chem Inf Model (2010) 0.99
Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect Immun (2013) 0.99
A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. Mol Biochem Parasitol (2012) 0.99
Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes. Eukaryot Cell (2013) 0.98
Functional characterization of a redundant Plasmodium TRAP family invasin, TRAP-like protein, by aldolase binding and a genetic complementation test. Eukaryot Cell (2008) 0.98